Tg Therapeutics Balance Sheet (2010-2026) | TGTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	401.71M	326.51M	298.89M	185.68M	147.07M	109.86M	102.30M	61.47M	97.01M	150.90M	92.93M	75.48M	82.91M	195.82M	0.37M	132.14M	1.34M	74.08M	1.32M	572.80M
Short-term Investments (Quarter)	41.75M	30.34M	15.88M	47.52M	48.64M	66.08M	59.37M	78.24M	47.90M	78.26M	124.58M	134.31M	134.34M	145.22M	131.11M	144.10M	122.74M	57.50M	62.82M	72.22M
Cash & Current Investments (Quarter)	443.46M	356.85M	314.76M	233.20M	195.71M	175.94M	161.68M	139.71M	144.91M	229.16M	217.51M	209.78M	217.25M	341.04M	131.48M	276.24M	124.08M	131.58M	64.14M	645.02M
Receivables - Net (Quarter)	0.93M	1.38M	1.39M	0.90M	0.09M			8.62M	17.48M	39.32M	51.09M	64.98M	83.61M	115.73M	129.19M	13.40M	231.52M	265.38M	305.63M	392.05M
Receivables - Other (Quarter)										6.80M	5.90M	6.50M			23.50M
Receivables (Quarter)	0.93M	1.38M	1.39M	0.90M	0.09M			8.62M	17.48M	46.12M	56.99M	71.48M	83.61M	115.73M	152.69M	13.40M	231.52M	265.38M	305.63M	392.05M
Raw Materials (Quarter)								0.02M	0.02M	1.23M	6.58M	1.71M	1.74M	1.73M	28.15M	4.12M	4.12M	4.06M
Work In Process (Quarter)								27.14M	29.55M	31.71M	31.24M	74.10M	77.89M	74.97M	68.37M	142.92M	129.24M	121.81M
Finished Goods (Quarter)								0.05M	0.66M	0.61M	2.00M	1.90M	1.61M	7.96M	13.94M	10.72M	21.84M	21.09M
Inventory (Quarter)								27.22M	30.23M	33.55M	39.82M	77.72M	81.24M	84.67M	110.46M	157.76M	155.20M	146.95M	125.59M	129.03M
Prepaid Assets (Quarter)	7.73M	2.50M	2.88M	4.09M	3.14M	4.03M	4.24M	4.46M	4.86M	5.00M	9.52M	8.10M	7.05M	32.63M	15.72M	20.39M	25.37M	55.85M	57.58M	51.46M
Current Assets (Quarter)	455.07M	371.78M	330.96M	242.22M	202.56M	182.92M	168.27M	184.78M	208.57M	319.11M	317.94M	360.58M	389.15M	574.07M	566.36M	644.51M	663.96M	599.76M	630.76M	1,086.97M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.60M	0.60M	0.60M	0.53M	0.45M	0.38M	0.31M	0.24M	0.21M	0.13M	0.10M	0.07M
Long-Term Investments (Quarter)	12.76M	24.55M	35.53M	47.47M	36.08M	21.77M	12.40M					1.32M	0.95M	1.12M	0.81M	1.91M	28.59M	48.76M	59.14M	61.54M
Goodwill (Quarter)	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M
Goodwill & Intangibles (Quarter)	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M	0.80M
Long-Term Deferred Tax (Quarter)																		366.63M	348.00M	344.14M
Other Non-Current Assets (Quarter)	1.26M	1.26M	1.26M	1.26M	1.27M	1.27M	1.27M	1.28M	1.28M	1.28M	2.31M	1.29M	2.15M	1.29M	1.30M	1.30M	1.32M	2.04M	1.34M	1.35M
Non-Current Assets (Quarter)	26.33M	37.91M	48.66M	60.81M	49.11M	34.97M	25.30M	12.57M	12.28M	11.95M	11.64M	12.74M	12.06M	11.95M	11.33M	12.18M	38.65M	425.26M	432.49M	441.87M
Assets (Quarter)	481.40M	409.69M	379.63M	303.03M	251.67M	217.89M	193.57M	197.36M	220.85M	331.07M	329.59M	373.32M	401.21M	586.01M	577.69M	656.69M	702.61M	1,025.02M	1,063.25M	1,528.84M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	40.23M	44.70M	51.29M	49.67M	37.22M	29.73M	42.02M	57.09M	62.95M	39.74M	38.47M	87.27M	93.47M	101.41M	58.30M	28.10M	134.02M	112.34M	107.51M	148.84M
Notes Payables (Quarter)
Payables (Quarter)	40.23M	44.70M	51.29M	49.67M	37.22M	29.73M	42.02M	57.09M	62.95M	39.74M	38.47M	87.27M	93.47M	101.41M	58.30M	28.10M	134.02M	112.34M	107.51M	148.84M
Accumulated Expenses (Quarter)	8.51M	12.86M	10.17M	1.62M	2.88M	4.30M	8.43M	3.22M	6.64M	8.34M	12.17M	3.60M	6.35M	10.09M	15.19M	5.13M	10.61M	15.01M	21.85M	18.66M
Other Accumulated Expenses (Quarter)	14.15M	12.63M	1.51M	1.87M	1.74M	0.81M	1.17M	1.22M	1.57M	1.22M	1.48M	4.06M	4.16M	3.30M	4.63M	2.95M	2.26M	1.99M	2.12M	0.60M
Short term Debt (Quarter)	23.16M	16.00M	0.97M
Current Leases (Quarter)	1.50M	1.47M	1.44M	1.49M	1.48M	1.62M	1.58M	1.55M	1.51M	1.48M	1.45M	1.38M	1.31M	1.23M	1.16M	1.12M	1.09M	1.07M	1.04M	1.82M
Current Deferred Revenue (Quarter)	0.70M	0.60M	0.60M	0.60M	0.50M	0.50M	0.50M	0.40M	0.40M	6.90M	0.15M	3.37M	3.37M	9.09M	11.41M	17.08M	23.91M	26.40M	21.23M	17.19M
Total Current Liabilities (Quarter)	87.55M	87.66M	65.38M	54.66M	43.33M	36.45M	53.20M	63.08M	72.67M	57.68M	53.72M	99.68M	108.66M	125.11M	90.68M	160.21M	171.89M	156.81M	153.76M	187.11M
Non-Current Liabilities
Non-Current Debt (Quarter)			66.79M	67.25M	68.95M	71.14M	71.14M	96.50M	97.70M	98.91M	100.12M	101.33M	102.54M	244.16M	244.43M	244.73M	245.04M	245.34M	245.65M	745.14M
Non-Current Deffered Revenue (Quarter)	0.53M	0.49M	0.46M	0.42M	0.38M	0.34M	0.30M	0.27M	0.23M	0.19M	6.02M	3.24M	3.74M	16.17M	12.09M	6.60M	1.67M	8.35M	8.81M	6.86M
Minority Interest (Quarter)
Operating Leases (Quarter)	10.19M	10.02M	9.85M	10.32M	9.98M	10.58M	10.34M	10.08M	9.80M	9.52M	9.23M	8.96M	8.70M	8.42M	8.13M	7.86M	7.59M	7.31M	7.02M	6.59M
Other Non-Current Liabilities (Quarter)	0.72M	0.62M	0.36M				0.24M				0.36M	2.79M	3.08M	3.08M	3.79M	2.16M	2.21M	1.96M	2.10M	0.78M
Total Non-Current Liabilities (Quarter)	97.55M	97.55M	142.12M				134.74M				168.73M	210.42M	220.56M	390.78M	351.54M	417.24M	423.97M	415.84M	413.13M	944.93M
Total Liabilities (Quarter)	98.27M	98.17M	142.48M	132.64M	122.63M	117.41M	134.99M	169.93M	180.40M	166.30M	169.09M	213.21M	223.64M	393.86M	355.33M	419.40M	426.18M	417.81M	415.23M	945.71M
Shareholder's Equity
Total Debt (Quarter)	23.16M	16.00M	67.76M	67.25M	68.95M	71.14M	71.14M	96.50M	97.70M	98.91M	100.12M	101.33M	102.54M	244.16M	244.43M	244.73M	245.04M	245.34M	245.65M	745.14M
Common Equity (Quarter)	383.13M	311.52M	237.15M	170.39M	129.03M	100.48M	58.59M	27.43M	40.45M	164.77M	160.50M	160.11M	177.57M	192.16M	222.36M	237.29M	276.43M	607.22M	648.02M	583.13M
Shareholder's Equity (Quarter)	383.13M	311.52M	237.15M	170.39M	129.03M	100.48M	58.59M	27.43M	40.45M	164.77M	160.50M	160.11M	177.57M	192.16M	222.36M	237.29M	276.43M	607.22M	648.02M	583.13M
Liabilities and Shareholders Equity (Quarter)	481.40M	409.69M	379.63M	303.03M	251.67M	217.89M	193.57M	197.36M	220.85M	331.07M	329.59M	373.32M	401.21M	586.01M	577.69M	656.69M	702.61M	1,025.02M	1,063.25M	1,528.84M
Treasury Shares (Quarter)	12.11M	2.47M	12.03M	0.04M	1.00M	0.04M	0.04M	0.04M	0.04M	4.86M	9.64M	0.04M	11.37M	0.13M	11.84M	12.94M	0.76M	3.54M	12.01M	8.35M
Retained Earnings (Quarter)	-1149.72M	-1235.36M	-1328.70M	-1400.00M	-1438.22M	-1474.04M	-1527.03M	-1566.27M	-1613.88M	-1499.94M	-1552.58M	-1500.00M	-1600.00M	-1552.53M	-1529.19M	-1500.00M	-1500.00M	-1100.00M	-1082.02M	-1100.00M
Preferred Shares (Quarter)

Research Tools

Developers

Tg Therapeutics Balance Sheet (2010-2026) | TGTX

Research Tools

Developers

Tg Therapeutics Balance Sheet (2010-2026) | TGTX

Create an account

Sign In

Reset Password